European Society of Toxicology In Vitro > Uncategorized > ESTIV welcomes two new corporate members!
26 July 2021

ESTIV welcomes two new corporate members!

React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use.For more information visit:
www.react4life.com
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, Symrise has set up an animal testing policy in 2009 that aims to minimize such testing and Symrise is promoting alternative approaches wherever possible.


For more information visit:
www.symrise.com

Related content

In Memory of Dr. Alan M. Goldberg (1939–2026)

The European Society of Toxicology In Vitro (ESTIV) joins the international scientific community in mourning the loss of Dr. Alan M. Goldberg, who passed away on 9 June 2026 at the age of 86.

The ESTIV congress – A journey that began before ESTIV itself…from Soesterberg to Maastricht

As we prepare for the 23rd ESTIV Congress in Maastricht in 2026, we found ourselves looking back at the remarkable history of our community.
Many people know that the European Society of Toxicology In Vitro (ESTIV) was formally established in 1994. What is less widely known is that the roots of ESTIV go much deeper.

Connecting early-career Researchers: ASPIS Academy, PARC Junior Community, and VICT3R ESR network

This interactive session, brings together early-career researcher communities from three major European initiatives in toxicology and chemical safety: the ASPIS Academy, the PARC Junior Community, and the VICT3R Early Stage Researcher Network.

Silver Sponsor

Communication partners

Memorandum of Understanding